Biological effects of progestins in breast cancer

Gynecological Endocrinology

Volumn 15, Issue SUPPL. 6, 2001, Pages 44-52

  Pasqualini, J R ^a   Ebert, C ^b   Chetrite, G S ^a  

^a Institut de Puericulture   (France)

^b Solvay Pharmaceuticals GmbH   (Germany)

Author keywords

Breast cancer; Estrogens; Progestins

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; ESTRONE SULFATASE; GESTAGEN; HYDROXYSTEROID DEHYDROGENASE; PROGESTERONE RECEPTOR; SULFATASE; SULFOTRANSFERASE;

BIOSYNTHESIS; BREAST TUMOR; CELL DIVISION; CLASSIFICATION; DRUG EFFECT; FEMALE; HUMAN; METABOLISM; PATHOLOGY; REVIEW;

17-HYDROXYSTEROID DEHYDROGENASES; BREAST NEOPLASMS; CELL DIVISION; ESTROGENS; FEMALE; HUMANS; PROGESTINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SULFATASES; SULFOTRANSFERASES;

EID: 0141841217     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/gye.15.s6.44.52     Document Type: Article

References (64)

1. Longacre TA, Bartow SA. A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 1986;10: 382-93
2. Topper YJ, Freeman CS. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 1980;60:1049-106
3. van Bogaert LJ. Effect of hormone on human mammary duct in vivo. Horm Metab Res 1978;10: 337-40
4. McManus MJ, Welsch CW. The effect of estrogen, progesterone, thyroxine, and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice. Cancer 1984;54:1920-7
5. Laidlaw IJ, Clarke RB, Howell A, et al. The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology 1995;136: 164-71
6. Gompel A, Malet C, Spritzer P, et al. Progestin effect on cell proliferation and 17β-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. J Clin Endocrinol Metab 1986;63: 1174-80
7. Longman SM, Buehring GC. Oral contraceptives and breast cancer. In vitro effect of contraceptive steroids on human mammary cell growth. Cancer 1987;59:281-7
8. Jones B, Russo J. Influence of steroid hormones on the growth fraction of human breast carcinomas. Am J Clin Pathol 1987;88:132-8
9. Botella J, Duranti E, Duc I, et al. Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T-47D human breast cancer cells. J Steroid Biochem Mol Biol 1994;50:41-7
10. Vignon F, Bardon S, Chalbos D, et al. Anti-estrogenic effect of R-5020, a synthetic progestin in human breast cancer cells in culture. J Clin Endocrinol Metab 1983;56:1124-30
11. Horwitz KB, Freidenberg GR. Growth inhibition and increase of insulin receptors in antiestrogen-resistant T-47Dco human breast cancer cells by progestins: implication for endocrine therapies. Cancer Res 1985;45:167-73
12. Murphy LC, Dotzlaw H, Alkhalaf M, et al. Mechanisms of growth inhibition by antiestrogens and progestins in human breast and endometrial cancer cells. J Steroid Biochem Mol Biol 1992;43:117-21
13. Musgrove EA, Lee CS, Sutherland RL. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos and c-myc genes. Mol Cell Biol 1991;11:5032-43
14. Jeng M-H, Parker CJ, Jordan VC. Estrogenic potential of progestins in oral contracteptives to stimulate human breast cancer cell proliferation. Cancer Res 1992;52:6539-46
15. Kalkhoven E, Kwakkenbos-Isbrücker L, de Laat SW, et al. Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor. Mol Cell Endocrinol 1994;102: 45-52
16. Papa V, Reese CC, Brunetti A, et al. Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells. Cancer Res 1990;50:7858-62
17. Hissom JR, Moore MR. Progestin effects on growth in the human breast cancer cell line T-47D - possible therapeutic implications. Biochem Biophys Res Commun 1987;145:706-11
18. Catherine WH, Jeng M-H, Jordan VC. Norgestrel and gestodene stimulate breast cancer cell growth through an estrogen receptor mediated mechanism. Br J Cancer 1993;67:945-52
19. Schatz RW, Soto AM, Sonnenschein C. Effects of interaction between estradiol-17β and progesterone on the proliferation of cloned breast tumor cells (MCF-7 and T-47D). J Cell Physiol 1985;124:386-90
20. Markiewicz L, Hochberg RB, Gurpide E. Intrinsic estrogenicity of some progestagenic drugs. J Steroid Biochem Mol Biol 1992;41:53-8
21. Markiewicz L, Gurpide E. Estrogenic and progestagenic activities coexisting in steroidal drugs: quantitative evaluation by in vitro bioassays with human cells. J Steroid Biochem Mol Biol 1994; 48:89-94
22. Botella J, Porthe-Nibelle J, Paris J, et al. Interaction of new 19-nor progesterone derivatives with progestagen, mineralocorticoid and glucocorticoid cytosolic receptors. J Pharmacol 1986;17:699-706
23. Catherine WH, Jordan VC. Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity. J Steroid Biochem Mol Biol 1995;55:239-46
24. Thuneke I, Schulte HM, Bamberger AM. Biphasic effect of medroxyprogesterone-acetate (MPA) treatment on proliferation and cyclin D1 gene transcription in T47D breast cancer cells. Breast Cancer Res Treat 2000;63:243-8
25. van der Berg B, Kalkhoven E, Isbrücker L, et al. Effects of progestins on the proliferation of oestrogen-dependent human breast cancer cells under growth factor-defined conditions. J Steroid Biochem Mol Biol 1992;42:457-69
26. Hissom JR, Bowden RT, Moore MR. Effects of progestins, estrogens and antihormones on growth and lactate dehydrogenase in the human breast cancer cell line T-47D. Endocrinology 1989;125: 418-23
27. Nardulli AM, Greene GL, O'Malley BW, et al. Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology 1988;122:935-44
28. Alexander IE, Shine J, Sutherland RL. Progestin regulation of estrogen receptor messenger RNA in human breast cancer cells. Mol Endocrinol 1990;4: 821-8
29. Perez-Palacios G, Cerbon MA, Pasapera AM, et al. Mechanisms of hormonal and antihormonal action of contraceptive progestins at the molecular level. J Steroid Biochem Mol Biol 1992;41:479-85
30. Read LD, Snider CE, Miller JS, et al. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Mol Endocrinol 1988;2: 263-71
31. Goldfine ID, Papa V, Vignerie R, et al. Progestin regulation of insulin and insulin-like growth factor-I (IGF-I) receptors in cultured human breast cancer cells. Breast Cancer Res Treat 1992; 22:69-79
32. Papa V, Hartmann KKP, Rosenthal SM, et al. Progestins induce down-regulation of insulin-like growth factor (IGF-I) receptors in human breast cancer cells: potential autocrine role of IGF-II. Mol Endocrinol 1991;5:709-17
33. Yee D. The insulin-like growth factor system as target in breast cancer. Breast Cancer Res Treat 1994;32:85-95
34. Alkhalaf M, Murphy LC. Regulation of c-jun and jun-B by in T-47D human breast cancer cells. Mol Endocrinol 1992;6:1625-33
35. Wong MMSJ, Murphy LC. Differential regulation of c-myc by progestins and antiestrogens in T-47D human breast cancer cells. J Steroid Biochem Mol Biol 1991;39:39-44
36. Moore MR, Zhou J-L, Blankenship KA, et al. A sequence in the 5′ flanking region confers progestin responsiveness on the human c-myc gene. J Steroid Biochem Mol Biol 1997;62:243-52
37. Hurd C, Khattree N, Alban P, et al. Hormonal regulation of the p53 tumor suppressor protein in T-47D human breast carcinoma cell line. J Biol Chem 1995;270:28507-10
38. Lipton A, Santner SJ, Santen RJ, et al. Aromatase activity in primary and metastatic human breast cancer. Cancer 1987;59:779-82
39. Perel E, Daniilescu D, Kharlip L, et al. Steroid modulation of aromatase activity in human cultured breast carcinoma cells. J Steroid Biochem Mol Biol 1988;29:393-9
40. Dao TL, Hayes C, Libby PR. Steroid sulfatase activities in human breast tumors. Proc Soc Exp Biol Med 1974;146:381-4
41. PasqualiniJR, Gelly C, Nguyen B-L, et al. Importance of estrogen sulfates in breast cancer. J Steroid Biochem Mol Biol 1989;34:155-63
42. Pasqualini JR, Gelly C, Lecerf F. Biological effects and morphological responses to estriol, estriol-3-sulfate, estriol-17-sulfate and tamoxifen in a tamoxifen-resistant cell line (R-27) derived from MCF-7 human breast cancer cells. Eur J Cancer Clin Oncol 1986;22:1495-501
43. Santner SJ, Feil PD, Santen RJ. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. J Clin Endocrinol Metab 1984;59:29-33
44. Pasqualini JR, Chetrite G, Blacker C, et al. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer. J Clin Endocrinol Metab 1996;81:1460-4
45. Pasqualini JR, Ebert C, Chetrite G. Control of estradiol in human breast cancer. Effect of medrogestone on sulfatase, 17β-hydroxysteroid dehydrogenase and sulfotransferas es activities in human breast cancer cells. In Proceedings of the IV European Congress on Menopause. Paris: Editions ESKA, 1998:625-33
46. Pasqualini JR, Varin C, Nguyen B-L. Effect of the progestagen R-5020 (promegestone) and of progesterone on the uptake and on the transformation of estrone sulfate in the MCF-7 and T-47D human mammary cancer cells: correlation with progesterone receptor levels. Cancer Lett 1992;66:55-60
47. Chetrite G, Paris J, Botella J, et al. Effect of nomegestrol acetate on estrone-sulfatase and 17β-hydroxysteroid dehydrogenase activities in human breast cancer cells. J Steroid Biochem Mol Biol 1996;58:525-31
48. Nguyen B-L, Fermé I, Chetrite G, et al. Action of danazol on the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D and MDA-MB-231 human mammary cancer cells. J Steroid Biochem Mol Biol 1993;46:17-23
49. Carlström K, Doberl A, Pousette A, et al. Inhibition of steroid sulfatase activity by danazol. Acta Obstet Gynecol Scand 1984;123(Suppl):107-11
50. Evans TRJ, Rowlands MG, Jarman M, et al. Inhibition of estrone sulfatase enzyme in human placenta and human breast carcinoma. J Steroid Biochem Mol Biol 1991;39:493-9
51. Chetrite G, Varin C, Delalonde L, et al. Effect of promegestone, tamoxifen, 4-hydroxytamoxifen and ICI 164,384 on the oestrone sulphatase activity of human breast cancer cells. Anticancer Res 1993; 13:931-4
52. Pasqualini JR, Maloche C, Maroni M, et al. Effect of the progestagen promegestone (R-5020) on mRNA of the oestrone sulphatase in the MCF-7 human mammary cancer cells. Anticancer Res 1994; 14:1589-94
53. Andersson S, Moghrabi N. Physiology and molecular genetics of 17β-hydroxysteroid dehydrogenases. Steroids 1997;62:143-7
54. Adamski J, Jakob FJ. A guide to 17β-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 2001;171:1-4
55. Nguyen B-L, Chetrite G, Pasqualini JR. Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol and promegestone (R-5020). Breast Cancer Res Treat 1995;34:139-46
56. Malet C, Vacca A, Kuttenn F, et al. 17β-Hydroxysteroid dehydrogenase (E2DH) activity in T47D cells. J Steroid Biochem Mol Biol 1991;39: 769-75
57. Adams EF, Coldham NG, James VHT. Steroidal regulation of oestradiol-17β-dehydrogenase activity of the human breast cancer cell line MCF-7. J Endocrinol 1988;118:149-54
58. Coldham NG, James VHT. A possible mechanism for increased breast cell proliferation by progestins through increased reductive 17β-hydroxysteroid dehydrogenase activity. Int J Cancer 1990;45:174-8
59. Couture P, Thériault C, Simard J, et al. Androgen receptor-mediated stimulation of 17β-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Endocrinology 1993;132:179-85
60. Poutanen M, Isomaa V, Kainulainen K, et al. Progestin induction of 17β-hydroxysteroid dehydrogenase enzyme protein in the T-47D human breast cancer cell line. Int J Cancer 1990; 46:897-901
61. Anderson E, Howell A. Oestrogen sulphotransferases in malignant and normal human breast tissue. Endocr Relat Cancer 1995;2:227-33
62. Luu-The V, Bernier F, Dufort I. Steroid sulfotransferases. J Endocrinol 1996;150:587-97
63. Chetrite G, Le Nestour E, Pasqualini JR. Estrogen sulfotransferase activities and its mRNA in various breast cancer cell lines. Effect of the progestin, promegestone (R-5020). J Steroid Biochem Mol Biol 1998;66:295-302
64. Chetrite GS, Ebert C, Wright F, et al. Control of sulfatase and sulfotransferase activities by medrogestone in the hormone-dependent MCF-7 and T-47D human breast cancer cell lines. J Steroid Biochem Mol Biol 1998;70:39-45